Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?

NCT00291720 is registered in ClinicalTrials.gov with University Hospital Birmingham as lead sponsor.

NCT NCT00291720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00291720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
Lead sponsor
University Hospital Birmingham
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2005
Completion date
December 31, 2007
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, chronic kidney disease